CD19 and neoplasm: In this aggressive and fast‐growing tumor model, CD19/CD3ε FP T cells delayed tumor growth (Figure 4c) and mice showed significant survival advantage compared to NT T cell and CD19 CAR‐T cell treated mice (Figure 4d,e).